Clinical impact of ENIGMA-based variant reclassification on genotype-phenotype analyses in BRCA1- and BRCA2-associated hereditary breast and ovarian cancer.
Medicine
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.